Thus, a preponderance of evidence from human lesions and from animal models suggests CCMs are generated from a combination of an activating variant in an oncogene such as PIK3CA or AKT1, which was recently identified in a single case24, plus either biallelic loss in a CCM gene or an activating variant in MAP3K3. This evidence concerns the gene MAP3K3 and cerebral cavernous malformation.